MedPath

Spot Depression Study

Completed
Conditions
Bipolar Disorder
Depressive Disorder
Interventions
Procedure: Online questionnaire and self-administered blood spot
Registration Number
NCT02804867
Lead Sponsor
University of Cambridge
Brief Summary

This study aims to identify signs of depression and bipolar disorder by measuring changes of certain molecules (biomarkers) that can be detected in dried blood spots. Our goal is to use these biomarkers to develop a diagnostic test to enable early treatment, which can lead to better patient outcomes.

Detailed Description

Bipolar disorder and major depression are serious mental health conditions that have a devastating impact on patients, their families and friends, and society. Currently, no laboratory test exists for these disorders. We are trying to develop a molecular test based on blood spots (small spots of blood obtained from patients' fingertips that have been dried on special paper). Volunteers take part by filling out the questionnaire at www.spot-depression.org. They may then be selected to provide a dried blood spot, which can be collected at home using a kit that will be mailed to their address.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Residing in the United Kingdom
  • Over 18 years of age
Exclusion Criteria
  • Pregnant or breastfeeding
  • Presence of blood-borne infection

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ControlOnline questionnaire and self-administered blood spot-
Bipolar disorderOnline questionnaire and self-administered blood spot-
DepressionOnline questionnaire and self-administered blood spot-
Primary Outcome Measures
NameTimeMethod
Assessment of classification accuracy of protein concentrations in dried blood spots for distinguishing between bipolar disorder and depressionBaseline (at enrollment); no follow-up
Comparison of protein concentrations in dried blood spots between patient groups and controlsBaseline (at enrollment); no follow-up
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Jordan Ramsey

🇬🇧

Cambridge, Cambridgeshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath